arterial blood gases in ed: rest in peace?
Embed Size (px)
DESCRIPTION
This presentation, the keynote address at CEM 2014 (UK), tests the theory that arterial blood gases are no longer needed in emergency department decision-making for many patients. Though cases, it explores the risks and benefits of a venous blood gas approach.TRANSCRIPT

ARTERIAL BLOOD GASES:
REST IN PEACE?
Anne-Maree KellyProfessor and DirectorJoseph Epstein Centre for Emergency Medicine Research @Western Health

PERMISSION TO USE
Professor Kelly gives permission for this material to be used for educational purposes (personal or group) on the basis that:•The original source is acknowledged•No liability is accepted by her for the currency or setting relevance of the content

Conflicts of interest
No conflicts of interest to declare.
I have not received industry funding for any of my blood gas research.

Why I go interested
I am a ‘woose’ I dislike needles and am averse to pain
My experience Late presentation of asthma and DKA because of fear of
ABG More severe illness, that was potentially preventable
Was there another way?

This session’s objectives
To understand the agreement performance of variables on arterial and venous blood gas analysis
To be aware of how venous blood gas analysis can be safely used in clinical decision-making
To be aware of grey areas and unanswered questions

Caveat
Discussion will be limited to comparisons between arterial and peripheral venous samples as these are the most relevant to Emergency Medicine practice

Blood gases in emergency medical care
Establishing acid-base status Mainly pH; but also bicarbonate
Measuring respiratory function/ ventilation Mainly pCO2; but also pH
‘Quick check’ potassium, haematocrit, some electrolytes

Why venous rather than arterial?
Less pain for patients Fewer complications, especially vascular and
infection Fewer needle-stick injuries to staff Easier blood draw Minimal training requirement

Key questions
Is my patient hypoxic? Does this patient have
respiratory failure? Is this patient a CO2
retainer? Do I need to provide
additional ventilatory support?
Is my treatment working?
Is my patient acidotic/ alkalotic?
What sort of acid-base disturbance do they have?
Is my treatment working?
Respiratory Disease Metabolic disease

Setting the context
JANE
26 year old, insulin dependent diabetic
2 days of vomiting and diarrhoea
Pulse 120 bpm, BP 100/-, BSL ‘Hi’
Would you: 1. Take an ABG to establish
acid/base status 2. Take an ABG to establish
acid/base & potassium status 3. Take a VBG to establish
acid/base status 4. Take a VBG to establish
acid/base and potassium status

Setting the context
JANE
26 year old, insulin dependent diabetic
2 days of vomiting and diarrhoea
Pulse 120 bpm, BP 100/-, bedside glucose ‘Hi’
VBG result: pH – 7.26 pCO2 – 16 mmHg HCO3 – 7.1 mmol/l K – 3.8 mmol/l BE -14
Is this data enough to guide clinical decision-making?
1. No 2. Yes Unsure

Setting the context
Would you: 1. Obtain an ABG for pO2, pCO2
and pH 2. Obtain a VBG for pCO2 and
pH 3. Obtain a VBG for pH and to
screen for hypercarbia 4. Proceed initially on clinical
features and pulse oximetry without blood gas analysis
TRAN
74 year old male; known COAD
Acute respiratory distress Pulse 118, BP 140/-,
respiratory rate 35, SpO2 (air) 86%

Setting the context
VBG result: pH – 7.16 pCO2 – 82.6mmHg HCO3 – 28.8 mmol/l
Is this data enough to guide clinical decision-making?
1. No 2. Yes Unsure
TRAN
74 year old male; known COAD
Acute respiratory distress Pulse 125, BP 140/-,
respiratory rate 35, SpO2 (air) 86%

Setting the context
VBG result: pH – 7.45 pCO2 – 42 mmHg HCO3 – 28.7 mmol/l
Is this data enough to guide clinical decision-making?
1. No 2. Yes Unsure
TRAN
74 year old male; known COAD
Acute respiratory distress Pulse 118, BP 140/-,
respiratory rate 30, SpO2 (air) 86%
What about this?

Statistical considerations
Outcome of interest is how closely venous and arterial values agree, not how well they correlate
Weighted mean difference gives an estimate of the accuracy between the methods
95% limits of agreement give information about precision
Arterial value
Venous value
95% LoA

Clinical considerations
There is limited data about the tolerance clinicians have with respect to agreement between arterial and venous values of blood gas parameters
Depending on this tolerance, the degree of agreement may be acceptable or unacceptable There is also considerable variation between clinicians
regarding this tolerance!

Issues with the evidence
A number of relatively small studies Patient cohorts are highly varied Patient groups of interest are those at high risk of
acidosis or hypercarbia Reporting does not always provide this detail Data is often dominated by patients with normal pH,
pCO2 and blood pressure

pH
13 studies Range from 44 to 346 patients
Various conditions DKA (3), COAD (4), trauma (1)
2009 patients Weighted mean difference of 0.033 pH units 95% limits of agreement generally within +/- 0.1 pH units

pH in illness subgroups
DKA 3 studies (265 patients) Weighted mean
difference = 0.02 pH units
95% limits of agreement = -0.009 to 0.02 pH units (1 study)
COAD 5 studies (643 patients) Weighted mean
difference= 0.034 pH units
95% limits of agreement generally +/- 0.1

Clinical bottom line
In patients without severe circulatory compromise, agreement between arterial and venous values for pH in both metabolic and respiratory conditions is close.
Level of a agreement is probably clinically acceptable to clinicians.

pCO2
8 studies 965 patients Various conditions
COAD 4 Weighted mean difference = 6.2 mmHg 95% limits of agreement: up to -17.4 to +23.9 mmHg
5/7 studies reporting LoA report LoA band >20mmHg

pCO2 COAD
4 studies 452 patients Weighted man difference = 7.26 mmHg 95% limits of agreement: up to -14 to +26mmHg
All 3 studies that report LoA have LoA band >20mmHg

Clinical bottom line
Agreement between venous and arterial pCO2 is NOT good enough for clinical inter-changeability
BUT WAIT ......

Venous pCO2: A screening test for hypercarbia?
Author, year No. Screening cut-off
Sens. Spec. NPV %ABG avoided
Kelly, 2002 196
45 100 57 100 43
Kelly, 2005 107
45 100 47 100 29
Ak, 2006 132
45 100 * 100 33
McCanny, 2011
94 45 100 34 100 23
POOLED DATA
529
45 100 (95% CI 97-100)
53(95% CI 57-58)
100(95% CI 97-100)
35%(95% CI 32-41)
Data limited to studies in cohorts with respiratory disease

Using venous pH and CO2 to track progress? 1 study Average difference between change in pH (v-a) was 0.001
(LoA -0.7 to +0.7). Average difference between change in pCO2 (v-a) was
0.04mmHg (LoA -17.3 to +18.2). For both pH and pCO2, in the majority of cases the direction
of change was the same although the magnitude was variable.

Clinical bottom line
Agreement between venous and arterial pCO2 is NOT good enough for clinical inter-changeability
pCO2 on VBG is a reliable screening test for clinically relevant hypercarbia
In combination with clinical assessment, change in venous pH and pCO2 may be useful to monitor progress

Bicarbonate
8 studies 1211 patients Various conditions
COAD 2 Weighted mean difference = -1.3mmol/l 95% limits of agreement : up to +/- 5mmol/l

Bicarbonate in illness subgroups DKA
1 study (21 patients) Weighted mean
difference = -1.88 mmol/l
95% limits of agreement = -2.8 to 0.9 mmol/l
COAD 2 studies (643 patients) Weighted mean
difference= -1.34 mmol/l 95% limits of agreement:
none reported

Clinical bottom line
Limited data shows good agreement Evidence regarding 95% limits of agreement is
sparse Probably close enough agreement for classification
as high, low or normal Clinical acceptability may be context specific

Base excess
Two studies only In a sample of 103 patients (various conditions), they
report: mean difference of 0.089 95% limits of agreement -0.974 to +0.552
In 326 trauma patients mean difference -0.3 BE units 95% limits of agreement -4.4 to +3.9 BE units 20% did not fall within pre-defined clinical equivalence threshold
Current view: Agreement unclear. If accuracy is needed in critically ill, need ABG.

Potassium
2 studies in DKA comparing VBG vs serum K+ In both studies serum K+ is usually higher than BG
K+. Fu et al.
95% limits of agreement -0.96 to +1.19mmol/l 80% of patients had agreement within +/- 0.5mmmol/L
Roblas et al. Mean difference 1.13mmol/l (serum higher) 34% of patients had agreement within +/- 0.5 mmol/L.

Lactate
Limited data Systematic review by Bloom
Mean difference 0.25mmol/L LoA -2 to 2.3mmmol/L
Depending of where cut-off for clinical importance is set, significant misclassification rate
No data re accuracy of trend monitoring

Grey areas
Some data to suggest that AV agreement deteriorates in shock states
No data in mixed acid-base disorders Limited data in toxicological conditions

Is it just about the numbers?
Clinical decision-making isn’t just about the numbers
Clinical aspects of assessment are also important
Particularly the case in acute respiratory disease

Thinking again
JANE 26 year old, insulin dependent
diabetic 2 days of vomiting and
diarrhoea. Pulse 120 bpm, BP 100/-,
bedside glucose ‘Hi’
VBG result: pH – 7.26 pCO2 – 16mmHg HCO3 – 7.1 mmol/l K – 3.8 mmol/l
Is this data enough to guide clinical decision-making?
1. No
2. Yes
pH and bicarbonate agreement are good – clinically interchangeable
Be careful about error margin of K+ at extremes of the normal range – will always need serum value

Thinking again
VBG result: pH – 7.16 pCO2 – 82.6mmHg HCO3 – 28.8 mmol/l
Is this data enough to guide clinical decision-making?
1. No
2. Yes
TRAN 74 year old known COAD Acute respiratory distress Pulse 125, BP 140/-, respiratory
rate 35, SpO2 (air) 86%
pH is accurate - clinically interchangeable
pCO2 (even with LoA error) is clearly high
Clinically hypoxicHigh respiratory & pulse rateNeeds NIV

Thinking again
VBG result: pH – 7.45 pCO2 – 42 mmHg HCO3 – 28.7 mmol/l
Is this data enough to guide clinical decision-making?
1. No
2. Yes
TRAN 74 year old known COAD Acute respiratory distress Pulse 118, BP 140/-,
respiratory rate 30, SpO2 (air) 86%
pH is accurate – clinically interchangeablepCO2 is below screening cut-off for clinically relevant hypercarbiaDoes not need NIV

Take home messages
pH and bicarbonate probably close enough agreement for clinical purposes in DKA, acute respiratory failure,
isolated metabolic acidosis More work needed in toxicology, shock, mixed disease
pCO2 NOT enough agreement for clinical purposes, either as one-off or to monitor change Data suggests venous pCO2 is useful as a screening test
Base excess Agreement unclear
Potassium Beware the error margin at the extremes of the normal range
Lactate LoA wide and unclear if safe to use venous for trend

Questions?
Questions?
Vale ABG!